To improve the efficacy over antiplatelet monotherapy, dual antiplatelet therapy (DAPT) has
been increasingly adopted in the management of non-cardioembolic stroke. For minor …

During cerebral ischemia-reperfusion conditions, the excessive reactive oxygen species in
the ischemic penumbra region, resulting in neuronal oxidative stress, constitute the main …

Although stroke is typically understood to be a medical emergency, the same pertains when
cerebral ischemia produces seemingly mild or transient symptoms. For transient ischemic …

Background and Objectives Clopidogrel-aspirin initiated within 72 hours of symptom onset is
effective in patients with mild ischemic stroke or transient ischemic attack (TIA) in the …

Importance Prior trials showed that dual antiplatelet therapy could reduce the risk of early
new stroke in patients with acute mild ischemic stroke or transient ischemic attack (TIA) …

Background and purpose: Randomized controlled trials (RCTs) proved the efficacy of short-
term dual antiplatelet therapy (DAPT) in secondary prevention of minor ischemic stroke or …

Objectives Despite the potential spillover effect, the optimal duration of dual antiplatelet
therapy for minor stroke within 72 hours of symptom onset is still uncertain. Methods Safety …

Background Dual antiplatelet therapy (DAPT) with clopidogrel plus aspirin is a well-
established practice after a minor stroke or transient ischemic attack (TIA). However …

Background The optimal treatment for acute minor ischemic stroke is still undefined. and
options include dual antiplatelet treatment (DAPT), intravenous thrombolysis (IVT), or their …

Background We conducted a post hoc analysis of the ATAMIS (Antiplatelet Therapy in Acute
Mild to Moderate Ischemic Stroke) trial to investigate whether the priority of clopidogrel plus …